ArticleMolecular therapy. Advances2026

Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation.

Hayato Nakatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.